Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors

NCT06358677 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Solid Tumor
Locally Advanced Solid Tumor

Interventions

DRUG: Topical Tretinoin
OTHER: Placebo

Sponsor

University of Utah